Catalyst Wire Dossier Catalyst Wire Dossier

Letermovir

letermovir · Merck & Co.
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Letermovir, covering 2017-11-17 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - CYMEVALIII STEP1 [NA]

See pricing